Upregulated Histone Deacetylase 6 Associates with Malignant Progression of Melanoma and Predicts the Prognosis of Patients.
Zhicheng HuYanchao RongShuting LiShanqiang QuShaobin HuangPublished in: Cancer management and research (2020)
These findings validate the utility of HDAC6 expression as an independent biomarker for the prognostication of patients with cutaneous melanoma.